Episode Details
Back to EpisodesClinical update with Dr. Daniel Griffin
Description
In his weekly clinical update, Dr. Griffin deep dives into the durability of the antibody response following mpox vaccination, vaccine security, global mpox circulation, the origins of SARS-CoV-2, including a list TWiV episodes and combatting scientific misinformation, before reviewing the recent statistics on SARS-CoV-2 infection, the WasterwaterScan dashboard, where to find PEMGARDA, a reminder of how and when to use steroids to treat COVID-19, what do when healthcare workers succumb to SARS-CoV-2 infection, if remdesivir + dexamethasone lowers mortality of hospitalized COVID-19 patients and the finding of how SARS-CoV-2 infection impacts memory and cognition.
Subscribe (free): Apple Podcasts, RSS, emailBecome a patron of TWiV!
Links for this episode- Waning vaccine protection against mpox…..isn’t this the way the humoral immune response works? (CIDRAP) 1:46
- Uncontrollable mpox outbreak in Africa (Reuters) 4:10
- Antibodies elicited by the Jynneos vaccine against mpox contract after 6-9 months….can you believe? (medrxiv) 4:45
- Mpox vaccine for adolescents approved (Pharmaceutical Technology) 14:05
- Clade 1b mpox visiting India (CIDRAP) 15:05
- Mpox clade 1b in Kerala (ANI South Asia’s Leading Multimedia News Agency) 15:13
- US government orders $63M worth of small pox/mpox vaccine (Reuters) 15:34
- Mpox donations boosting global supply (US Department of Health and Human Services)
- 1 million mpox vaccine doses for Africa….with love from US government (CIDRAP) 15:55
- Speed doses of mpox vaccine (CIDRAP)
- Mpox vaccine donations (UNICEF) 17:35
- Bavarian Nordic mpox vaccine (Yahoo finances)
- Early epicenter of COVID-19 pandemic Huanan seafood market (Science) 23:07 <